<Disease><Name>GANG(M1)-GANGLIOSIDOSIS, TYPE II. LIPIDOSIS, LATE INFANTILE SYSTEMIC</Name><Synonym>GLIOSIDOSIS, GENERALIZED GM1, TYPE II, OR JUVENILE TYPE</Synonym><OMIM><Number>230600</Number><URL>http://omim.org/entry/230600</URL></OMIM><Orphanet><Number>354</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=354</URL></Orphanet><Protein><Number>Beta galactosidase</Number><URL>http://www.uniprot.org/uniprot/P16278</URL></Protein><ExPASy><Number /><URL /></ExPASy><Gene>3p22.3</Gene><ICD>E75.1</ICD><Summary>rare ;autosomal recessive;- infantile form Type I&#160;&#160; ;- late infantile/juvenile form Type II;- adult/chronic form Type III</Summary><Symptoms><symtomp><id>1942</id><symptom>ataxia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>4094</id><symptom>blue histiocytes / sea-blue histiocytes</symptom><category /></symtomp><symtomp><id>2226</id><symptom>cerebral atrophy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2117</id><symptom>CT, brain, abnormalities [-] / CT, kraniell, abnormal </symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2423</id><symptom>early death</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1979</id><symptom>feeding difficulties, poor feeding</symptom><category>GASTROINTESTINAL SYSTEM | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>3848</id><symptom>gait disturbance</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1715</id><symptom>infections (severe or recurrent)</symptom><category>GENERAL TOPICS | IMMUNE OR HEMATOLOGIC SYSTEM</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1941</id><symptom>motor retardation / motor developmental delay</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2213</id><symptom>MRI, brain, abnormalities [-]</symptom><category>LABORATORY FINDINGS | NERVOUS SYSTEM</category></symtomp><symtomp><id>1899</id><symptom>muscular rigidity</symptom><category>MUSCLES</category></symtomp><symtomp><id>1900</id><symptom>myoclonus</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1917</id><symptom>neurological deterioration / neurologic deterioration</symptom><category>GENERAL TOPICS | NERVOUS SYSTEM</category></symtomp><symtomp><id>2038</id><symptom>neutropenia (decreased neutrophils)</symptom><category>IMMUNE OR HEMATOLOGIC SYSTEM | LABORATORY FINDINGS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1739</id><symptom>optic atrophy</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1919</id><symptom>progressive neurologic defect</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1970</id><symptom>pyramidal signs</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1974</id><symptom>spastic diplegia/quadriplegia/tetraplegia</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>2248</id><symptom>X-ray, abnormalities</symptom><category>LABORATORY FINDINGS</category></symtomp></Symptoms><Metabolites><metabolite><id>890</id><name>beta-Galactosidase</name><specimen>fibroblasts</specimen><value>decreased</value><min>    </min><max>100.00</max><unit>% activity</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>891</id><name>beta-Galactosidase</name><specimen>leucocytes</specimen><value>decreased</value><min>    </min><max>100.00</max><unit>% activity</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>965</id><name>Oligosaccharides</name><specimen>urine</specimen><value>increased</value><min>    </min><max>    </max><unit>not detectable</unit><age>no data</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>4503</id><title>The GM1 and GM2 Gangliosidoses: Natural History and Progress toward Therapy</title><author>Regier DS,</author><journal>Pediatr Endocrinol Rev Suppl</journal><year>2016</year><book /><volume>13</volume><number>1</number><pages>663-673</pages><co_aut>et al.</co_aut></literature><literature><id>4502</id><title>GM1 gangliosidosis: review of clinical, molecular, and therapeutic aspects</title><author>Brunetti-Pierri N,</author><journal>Mol Genet Metab</journal><year>2008</year><book /><volume>94</volume><number>4</number><pages>391-396</pages><co_aut>Scaglia F</co_aut></literature><literature><id>154</id><title>&#223;-Galactosidase deficiency (&#223;-galactosidosis): GM1 Gangliosidosis and Morquio B disease</title><author>Suzuki Y</author><journal>The metabolic and molecular bases of inherited disease, 7/e; Editors: C.R.Scriver, A.L.Beaudet, W.S.Sly, D.Valle; McGraw-Hill Inc.</journal><year>1995</year><book /><volume>2</volume><number>90</number><pages>2785-2823</pages><co_aut>Sakuraba H, Oshima A</co_aut></literature><literature><id>252</id><title>Thalamic hyperdensity on CT in infantile GM1-gangiosidosis</title><author>Kobayashi O</author><journal>Brain Dev</journal><year>1994</year><book /><volume>16</volume><number>6</number><pages>472-474</pages><co_aut>Takashima S</co_aut></literature><literature><id>251</id><title>GM1 gangliosidosis type 2 in two siblings</title><author>Gascon GG</author><journal>J Child Neurol Suppl</journal><year>1992</year><book /><volume>7</volume><number>0</number><pages>S41-S50</pages><co_aut>Ozand PT, Erwin RE</co_aut></literature></Literatures></Disease>